Login
Login
National Data Archive
An Online Microdata Catalog
  • Home
  • Catalog
  • Citations
    Home / Central Data Catalog / ZWE_2012_PHC_V01_M / variable [F5]
central

Population Census 2012

Zimbabwe, 2012
Reference ID
ZWE_2012_PHC_v01_M
Producer(s)
Zimbabwe National Statistics Agency
Metadata
DDI/XML JSON
Created on
Apr 25, 2019
Last modified
Apr 25, 2019
Page views
1744
  • Study Description
  • Data Description
  • Get Microdata
  • Data Files
  • ch
  • hh
  • hl
  • tn
  • wm
CSV JSON

Took medicine in order to prevent malaria (MN13)

Data file: wm

Overview

Valid: 1105
Invalid: 17853
Type: Discrete
Decimal: 0
Range: -
Format:

Questions and instructions

Literal question
During any of these antenatal visits for the pregnancy, did you take any medicine in order to prevent you from getting malaria?
Categories
Value Category
1 Yes
2 No
8 DK
9 Missing
Sysmiss
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Interviewer instructions
During pregnancy, a woman's immune system is weakened, making her more susceptible to malaria infection than women who are not pregnant. Malaria in pregnant women can cause several complications that are dangerous to the mother and unborn child, including severe malaria and death, maternal anaemia and low birthweight in newborns. The World Health Organization recommends that pregnant women in malaria-endemic areas take a treatment dose of SP/Fansidar (usually three tablets taken all at once) as a preventive measure, once a month during the third trimester of pregnancy (months 7, 8 and 9 of the pregnancy). Such preventive treatment with SP/Fansidar, usually given during antenatal visits, is known as intermittent preventive treatment (IPT). The generic name for SP/Fansidar is sulfadoxine-pyrimethamine, and other brand names can exist. Other anti-malarial medicines can be used as a preventive measure as well.

Circle the code corresponding to the answer given. Medicines to prevent malaria include only those medicines that a woman takes during pregnancy when she does not already have malaria. If the respondent took medicines during pregnancy when she did not already have malaria, continue to the next question.

If the respondent did not take any medicine to prevent her from getting malaria, circle '2'. If she does not know whether she received treatment to prevent malaria during her last pregnancy, circle '8' for 'DK'. In both cases, skip to MN17.

If the respondent says that she had malaria or a fever during the pregnancy and was given medicines to treat the malaria or fever, this would not be considered preventive treatment. In such a case, circle '2' for 'No' and skip to MN17.
National Data Archive

© National Data Archive, All Rights Reserved.